allcancercure.com

Biogen Idec (NASDAQ: BIIB) and Neurimmune Therapeutics AG announced they have entered into an agreement for the worldwide development and commercialization of novel, fully human antibodies for the treatment of Alzheimer’s disease (AD). The alliance will focus on the development of antibodies that bind to amyloid beta (A?), pathogenic molecule thought to cause neurodegeneration and [...]

Alzheimer’s is on the shortlist to be one of Deloitte’s chosen charities for 2008 and 2009, and Deloitte staff across the country are voting for their favourite charities from the list. If we win, Deloitte pledge to raise £500,000 to support Alzheimer’s and dementia work in the UK. So if you, or someone you know, [...]

Affiris GmbH has been granted a Europe-wide patent for key elements of its Alzheimer’s vaccine. As a result, the company has exclusive rights of use to the peptide sequences for an innovative approach to vaccine development. The tolerability of the first Affiris vaccine, AFFITOPE AD01, is currently being tested as part of a phase I [...]

To celebrate National Alzheimer’s Disease Awareness Month this November, the Alzheimer’s Association, the leading resource for Alzheimer’s care, is launching a comprehensive portfolio of educational tools for Latinos, one of the fastest growing populations with the disease. There are currently 200,000 Latinos in America with Alzheimer’s and that number could increase to 1.3 million by [...]

For unknown reasons a protein called amyloid beta aggregates into toxic plaques in the brain, killing neurons. These plaques are one of the hallmarks of Alzheimer’s disease. Now two new animal studies show for the first time that the deadly transformation of amyloid beta into plaques can be prevented through an interaction between amyloid beta [...]

For reasons unknown, amyloid beta, a protein, aggregates into toxic plaques in the brain, destroying neurons. These plaques are one of the hallmarks of Alzheimer’s disease. Now two new animal studies show for the first time that the deadly transformation of amyloid beta into plaques can be prevented through an interaction between amyloid beta and [...]

A recently published special issue of the Journal of Alzheimer’s Disease contains the contributions from experts in the field of aging, dementia and Alzheimer’s disease, who attended the “Fourth Annual Meeting on Brain aging and Dementia: From successful aging to severe dementia.” Held in Perugia under the auspices of the Italian Psychogeriatric Association, a member [...]